Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis - Trial NCT06268951
Access comprehensive clinical trial information for NCT06268951 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Enrolling by invitation. The study focuses on Endometriosis. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Mayo Clinic
Timeline & Enrollment
N/A
Feb 01, 2024
Dec 01, 2027
Primary Outcome
Symptom severity due to abdominal wall endometriosis following ablation.
Summary
To determine the characteristics of recovery and symptom relief following ablation of
 abdominal wall endometriosis.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06268951
Non-Device Trial